Catalyst Wire Dossier Catalyst Wire Dossier

Binimetinib

binimetinib · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

40 regulatory and trial events tracked for Binimetinib, covering 2020-07-14 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib [Phase 4]

See pricing